A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe)
PURPOSE: Autosomal dominant hypocalcemia with hypercalciuria is a genetic disease characterized by hypoparathyroidism with hypercalciuria. We discovered a novel variant (p.Tyr825Phe[Y825F]) of the CASR gene in a neonate with congenital hypoparathyroidism and hypercalciuria and conducted a cell function study to determine whether the CASR-Y825F variant was pathogenic.
METHODS: To perform a functional study on CaSR-Y825F, we constructed expression vectors expressing wild-type (WT) CASR and CASR-Y825F. After transfection of each expression vector into HEK293 cells, we examined alterations in intracellular signaling. Mitogen-activated protein kinase (MAPK) signaling activity of HEK293 cells expressing CASR-WT or CASR-Y825F was determined. Changes in intracellular calcium ions ([Ca2+]i) by extracellular calcium ion ([Ca2+]e) stimulation were quantitatively compared and analyzed.
RESULTS: Cells expressing CASR-Y825F showed elevated of MAPK signaling (phospho-ERK [pERK], phospho-JNK [pJNK], phospho-p38 [pp38]) and increased [Ca2+]i levels at low [Ca2+]e stimulation compared with cells expressing CASR-WT. Additionally, [Ca2+]i levels in HEK293 cells expression CASR-WT and CASR-Y825F were determined at 340 nm/380 nm wavelength ratios using Fura-2 AM. At [Ca2+]e concentrations of 2.5 mM and 3 mM, the ratios of CASR-Y825F cells were higher (2.6 and 3.5, respectively) than those of CASR-WT cells (1.04 and 1.40, respectively).
CONCLUSION: This cell function study proved that the CASR-Y825F expressed in HEK293 cells elevated MAPK signaling (pERK, pJNK, pp38) and increased [Ca2+]i to induce hypocalcemia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Annals of pediatric endocrinology & metabolism - 26(2021), 1 vom: 20. März, Seite 24-30 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moon, Jung Eun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Ca2+-sensing receptor |
---|
Anmerkungen: |
Date Revised 15.04.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.6065/apem.2040022.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314446443 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314446443 | ||
003 | DE-627 | ||
005 | 20231225152743.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.6065/apem.2040022.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n1048.xml |
035 | |a (DE-627)NLM314446443 | ||
035 | |a (NLM)32871647 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Moon, Jung Eun |e verfasserin |4 aut | |
245 | 1 | 2 | |a A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe) |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a PURPOSE: Autosomal dominant hypocalcemia with hypercalciuria is a genetic disease characterized by hypoparathyroidism with hypercalciuria. We discovered a novel variant (p.Tyr825Phe[Y825F]) of the CASR gene in a neonate with congenital hypoparathyroidism and hypercalciuria and conducted a cell function study to determine whether the CASR-Y825F variant was pathogenic | ||
520 | |a METHODS: To perform a functional study on CaSR-Y825F, we constructed expression vectors expressing wild-type (WT) CASR and CASR-Y825F. After transfection of each expression vector into HEK293 cells, we examined alterations in intracellular signaling. Mitogen-activated protein kinase (MAPK) signaling activity of HEK293 cells expressing CASR-WT or CASR-Y825F was determined. Changes in intracellular calcium ions ([Ca2+]i) by extracellular calcium ion ([Ca2+]e) stimulation were quantitatively compared and analyzed | ||
520 | |a RESULTS: Cells expressing CASR-Y825F showed elevated of MAPK signaling (phospho-ERK [pERK], phospho-JNK [pJNK], phospho-p38 [pp38]) and increased [Ca2+]i levels at low [Ca2+]e stimulation compared with cells expressing CASR-WT. Additionally, [Ca2+]i levels in HEK293 cells expression CASR-WT and CASR-Y825F were determined at 340 nm/380 nm wavelength ratios using Fura-2 AM. At [Ca2+]e concentrations of 2.5 mM and 3 mM, the ratios of CASR-Y825F cells were higher (2.6 and 3.5, respectively) than those of CASR-WT cells (1.04 and 1.40, respectively) | ||
520 | |a CONCLUSION: This cell function study proved that the CASR-Y825F expressed in HEK293 cells elevated MAPK signaling (pERK, pJNK, pp38) and increased [Ca2+]i to induce hypocalcemia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Ca2+-sensing receptor | |
650 | 4 | |a Hypercalciuric Hypocalcemia | |
650 | 4 | |a Hypoparathyroidism | |
650 | 4 | |a Point mutation | |
700 | 1 | |a Yang, Hee-Young |e verfasserin |4 aut | |
700 | 1 | |a Wee, Gabbine |e verfasserin |4 aut | |
700 | 1 | |a ParK, Suk-Hyun |e verfasserin |4 aut | |
700 | 1 | |a Ko, Cheol Woo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of pediatric endocrinology & metabolism |d 2013 |g 26(2021), 1 vom: 20. März, Seite 24-30 |w (DE-627)NLM238949281 |x 2287-1012 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2021 |g number:1 |g day:20 |g month:03 |g pages:24-30 |
856 | 4 | 0 | |u http://dx.doi.org/10.6065/apem.2040022.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2021 |e 1 |b 20 |c 03 |h 24-30 |